- Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment2017 | First Faculty of Medicine
- HPLC analysis of drug preparation containing dexamethasone and chinchocaine hydrochloridePublication without faculty affiliation
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma2015 | Faculty of Medicine in Hradec Králové
- Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma2009 | First Faculty of Medicine
- Dexamethasone reduces methotrexate biliary elimination and potentiates its hepatotoxicity in rats2010 | Central Library of Charles University
- Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma2019 | First Faculty of Medicine
- Zonation of multidrug resistance-associated protein 2 in rat liver after induction with dexamethasone2008 | Central Library of Charles University
- Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR2018 | First Faculty of Medicine
- m-TOR associated stomatitis in everolimus treatment and significant prophylactic effect of dexamethasone solution in context of Bolero-2 and SWISH trials2017 | Faculty of Medicine in Pilsen
- Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells1999 | Second Faculty of Medicine
- Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex(R)) through basal iridectomy (Ando) in a pseudophakic patient2016 | Faculty of Medicine in Hradec Králové
- Zonation of multidrug resistance-associated protein 2 in rat liver after induction with dexamethasone2008 | Faculty of Medicine in Hradec Králové
- Dexamethasone and betamethasone administration during pregnancy affects expression and function of 11beta-hydroxysteroid dehydrogenase type 2 in the rat placenta2009 | Central Library of Charles University
- A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma2020 | First Faculty of Medicine
- Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia2012 | Faculty of Medicine in Hradec Králové
- Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer2003 | First Faculty of Medicine
- Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion2010 | Faculty of Medicine in Hradec Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Chemohormonal regimen of epirubicin, etoposide, and dexamethasone in patients with hormone-refractory prostate cancer2003 | First Faculty of Medicine
- Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial2023 | First Faculty of Medicine
- Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study2023 | First Faculty of Medicine
- Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study2017 | First Faculty of Medicine
- Single-Gene Congenic Strain Reveals the Effect of Zbtb16 on Dexamethasone-Induced Insulin Resistance2018 | First Faculty of Medicine
- Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma2018 | First Faculty of Medicine
- Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia2014 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine